OS2.1 Objective responses to chemotherapy in recurrent glioma do not predict better survival: A prospective analysis from the German Glioma Network

BACKGROUND: Outside of clinical trials, the occurrence of objective responses (OR) to chemotherapy in patients with recurrent gliomas is poorly characterized. Further, the predictive value of OR for progression-free survival (PFS) and overall survival (OS) in glioma patients is unclear. MATERIAL AND...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Bähr, O, Hentschel, B, Hattingen, E, Reusche, M, Tatagiba, M, Tonn, J, Schnell, O, Schackert, G, Westphal, M, Herrlinger, U, Pietsch, T, Reifenberger, G, Weller, M, Löffler, M, Steinbach, J P
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Oral Presentations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6144569/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy139.014
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados